Invasion and persistence of bacteria within host cells requires that they adapt to life in an intracellular environment. This adaptation induces bacterial stress through events such as phagocytosis and enhanced nutrient-restriction. During stress, bacteria synthesize a family of proteins known as heat shock proteins (HSPs) to facilitate adaptation and survival. Previously, we determined the Staphylococcus aureus HSP ClpC temporally alters bacterial metabolism and persistence. This led us to hypothesize that ClpC might alter intracellular survival. Inactivation of clpC in S. aureus strain DSM20231 significantly enhanced long-term intracellular survival in human epithelial (HaCaT) and endothelial (EA.hy926) cell lines, without markedly affecting adhesion or invasion. This phenotype was similar across a genetically diverse collection of S. aureus isolates, and was influenced by the toxin/ antitoxin encoding locus mazEF. Importantly, MazEF alters mRNA synthesis and/or stability of S. aureus virulence determinants, indicating ClpC may act through the mRNA modulatory activity of MazEF. Transcriptional analyses of total RNAs isolated from intracellular DSM20231 and isogenic clpC mutant cells identified alterations in transcription of α-toxin (hla), protein A (spa), and RNAIII, consistent with the hypothesis that ClpC negatively affects the intracellular survival of S. aureus in non-professional phagocytic cells, via modulation of MazEF and Agr.
type and the infecting S. aureus strain 4 . Persistence is an aggregate process that is dependent, in part, upon the bacterial abilities to adhere and be internalized by host cells. Alterations in the ability to adhere or invade would complicate the assessment of bacterial persistence. To eliminate the possibility that differences in persistence were due to changes in the competence of bacteria to adhere or be internalized, strain DSM20231 (syn. ATCC 12600), a S. aureus derivative of the type strain 533 R4 isolated from human pleural fluid, and known to exert a strong ClpC effect on stationary phase survival 8 , was assessed for its ability to adhere to and invade HaCaT and Ea.hy926 cells. When strain DSM20231 and its clpC derivatives were brought into contact with keratinocytes or endothelial cells by mild centrifugation, about one fifth of the bacteria remained associated with the eukaryotic cells after 90 min of co-incubation and washing ( Fig. 1a ), suggesting that bacterial adhesion to eukaryotic cells is largely independent of ClpC in S. aureus. To gain additional insights into the effect of ClpC on adhesion of S. aureus to eukaryotic cells at the single cell level, adhesion of strains DSM20231 and PBM001 to Ea.hy926 cells was also analyzed by single cell force spectroscopy (SCFS). In this method, a viable cell (here a single bacterium) is immobilized on the tip of an atomic force microscope (AFM) cantilever to create a bacterial probe. This bacterial probe is brought into physical contact with its substratum (here the extracellular matrix [ECM] of an epithelial cell), and after a certain contact time the bacterial probe is withdrawn to rupture the potentially formed bacterium-ECM interactions. The rupture force and rupture length are detected by the deflection of the AFM cantilever, which allows studying the interaction forces between a single bacterium and its substratum with nanometer spatial and piconewton force resolution 17 . Similar to the adhesion assays ( Fig. 1a ), the interaction forces between single bacteria and Ea.hy926 cells were comparable ( Fig. 1b-d , Table S1 ). These data strongly suggest that S. aureus adhesion to eukaryotic cells is independent of ClpC and will not interfere with persistence assays. The adherence of strain DSM20231 and its mutant derivatives to HaCaT and Ea.hy926 cells was equivalent, but this does not rule out the possibility that differences in internalization could alter persistence. To address this possibility, lysostaphin/gentamicin protection assays were used. Strain DSM20231 invaded both cell lines in a bacterial cell density-dependent manner ( Fig. 2a ). While increasing the multiplicity of infection (MoI) enhanced bacterial invasion, invasion was not proportional to the increased number of bacteria ( Fig. 2a ), suggesting that the uptake process can be saturated at high MoIs. At a high MoI, bacterial cytotoxicity can kill eukaryotic cell lines. To exclude this possibility, cell viability was assessed using propidium iodide (PI) following bacterial invasion. Neither HaCaT nor EA.hy926 cells displayed increased cell death rates at 24 post infection with S. aureus strain DSM20231 (Fig. 2b) , a result similar to that reported for S. aureus strains USA300, SH1000 and Cowan I 4 . Together, these results demonstrate that S. aureus strain DSM20231 can be reliably used in HaCaT and EA.hy926 cell lines for invasion and persistence assays.
S. aureus cytotoxicity is independent of ClpC.
To determine if ClpC affects invasion of keratinocytes and endothelial cells through altered cytotoxicity, HaCaT and EA.hy926 cells were challenged with strains DSM20231, PBM001, and the clpC complemented PBM001 derivative, and the cells were detached and viability was assessed by propidium iodide (PI) staining. All three strains were internalized into HaCaT or EA.hy926 cells with comparable efficiencies and equivalent numbers of cells retained the PI stain ( Fig. 3a , c, 0 h). To determine the cytotoxic effects of S. aureus infection in these eukaryotic cell lines, MTT (3-[4.5-dimethylthiazol-2-yl]-2 .5-diphenyltetrazolium bromide) based cell viability assays were performed. The metabolic activities of strain DSM20231 and PBM001 infected HaCaT cultures, at 96 h and 168 h post-infection, were equivalent to those of the controls (Fig. S1 ), indicating that the viability of this keratinocyte cell line is not markedly affected by the intracellular persisting S. aureus cells. EA.hy926 cultures infected with strains DSM20231 and PBM001, however, decreased cell metabolism later during persistence (i.e., 96 h and 168 h post infection) relative to the bacteria-free controls ( Fig. S1b ). Taken together, these data indicate that ClpC is not required for internalization and that it minimally alters cytotoxicity to non-professional phagocytic cells.
Deletion of clpC in S. aureus enhances intracellular survival in keratinocytes and endothelial cells.
The absence of differences in adhesion, internalization, and toxicity associated with ClpC allowed us to assess intracellular persistence without complicating circumstances. To do this, intracellular bacterial cell densities were determined at 24 h, 96 h, and 168 h post-infection of HaCaT and EA.hy926 cells ( Fig. 3 ). Within 24 h of internalization, HaCaT cells killed approximately 75% of the intracellular bacteria, irrespective of the presence of ClpC (Figs 3a, b ). Similar results were obtained with EA.hy926 cells (Figs 3c, d ). Interestingly, after 96 h and 168 h of cultivation, significantly greater numbers of viable bacteria were present in both HaCaT (5.2-fold and 20.3-fold, respectively) and EA.hy926 cells (3.2-fold and 24.9-fold, respectively) infected with the clpC mutant strain PBM001 relative to those infected with the wild-type strain. Complementation of clpC restored persistence to near wild-type levels (Fig. 3) .
The ability of S. aureus to persist in non-professional phagocytes can be affected by the bacterial genetic background 4 . To exclude that the intracellular survival phenotype attributed to ClpC is unique to strain DSM20231, the clpC mutation was transduced into S. aureus strains LS1, Newman, and SH1000, and persistence was assessed.
Irrespective of the genetic background, inactivation of clpC did not alter internalization of S. aureus (Fig. 4) or survival during the first 24 h post-infection. At 96 h post-infection all clpC mutants maintained significantly greater bacterial numbers than did the isogenic wild-type strains in HaCaT, while significantly increased cell numbers were observed in EA.hy926 cells after 168 h post-infection. Taken together, these data demonstrate that clpC inactivation enhances persistence in keratinocytes and endothelial cells and is unrelated to the strain background. These observations are consistent with ClpC activity being greatest late in the growth cycle of S. aureus 9 .
SCV formation by intracellularly persisting S. aureus is independent of ClpC. Earlier work
demonstrated that intracellular passage of S. aureus in eukaryotic cells enhances SCV formation 6, 18 . To assess whether ClpC enhances persistence of S. aureus via augmentation of SCV formation, we determined the ratios of SCVs formed in EA.hy926 cells after 168 h post-infection ( Fig. S2 ). Consistent with other S. aureus genetic lineages 6, 18 , strain DSM20231 produced SCVs upon intracellular passage (3.3 ± 1.5% of colonies with a colony area ≤10 than the average colony area of normal growing colonies). The clpC mutant PBM001 produced a slightly higher ratio of SCVs upon intracellular passage (4.5 ± 1.4%); however, this difference was not statistically significant (P = 0.242, Mann-Whitney U test). These findings suggest that the increased intracellular survival capacity of PBM001 in non-professional phagocytic cells is not due to an increased ability to form SCVs. www.nature.com/scientificreports www.nature.com/scientificreports/ ClpC enhanced intracellular survival of S. aureus requires MazEF. ClpCP modulates the activity of the MazEF toxin/antitoxin system by degrading the antitoxin, MazE, in a growth phase-dependent manner 12, 13 . Additionally, MazEF alters the intracellular survival of S. aureus in osteoblasts 15 , suggesting that ClpC might affect the intracellular survival of S. aureus through MazEF. To test this hypothesis, we created mazEF mutants in strains DSM20231 and PBM001 and assessed their ability to survive intracellularly (Fig. 5 ). Similar to strain DSM20231, all three derivatives had comparable numbers of internalized bacteria after 90 min of incubation with HaCaT and Ea.hy926 cells. As expected, we observed that strain PBM001 had significantly increased numbers of viable bacteria in HaCaT (Fig. 5a ) or Ea.hy926 (Fig. 5b ) cells after 168 h of cultivation relative to the wild-type strain. Deletion of mazEF in DSM20231 did not markedly alter the invasion and intracellular survival of the mutant in keratinocytes and endothelial cells. At 168 h post lysostaphin/gentamicin treatment, the mazEF deletion strain had reduced numbers of intracellularly surviving bacteria in HaCaT cells, however this was not statistical significant (P = 0.124, Mann-Whitney U test between WT and mazEF mutant). These findings are in contrast to those made by Kolenda and colleagues 15 , where deletion of mazEF in strain HG003 enhanced intracellular survival in osteoblasts at 24 and 48 h post infection. Interestingly, in the clpC mazEF double mutant, the numbers of surviving bacteria were equivalent to those of strain DSM20231 at all time points, indicating that PBM001 required an intact mazEF locus to augment its intracellular persistence in HaCaT and Ea.hy926 cells. Taken together, these data suggest that ClpC influences S. aureus intracellular survival in keratinocytes and endothelial cells, in part, via the modulation of MazEF activity. www.nature.com/scientificreports www.nature.com/scientificreports/ Inactivation of clpC alters the transcription of hla, RNAIII, and spa in vitro and in internalized bacteria. The pore-forming cytolysin α-toxin (encoded by hla) is an important virulence factor of S. aureus that is under multiple levels of control 19 . Deletion of hla in S. aureus enhances intracellular persistence in HaCaT cells 20 , and it inhibits apoptosis 21 . Interestingly, hla mRNA stability is decreased by MazF activity in strain Newman 22 , which is in part controlled by the ClpCP proteolytic complex 13 . Similarly, the stability of spa mRNA (protein A) is also affected by MazF activity in different S. aureus strains (Newman and HG003) 22, 23 . These observations are important because transcription of both hla and spa are altered in SCVs and persister cells 2 . To assess if ClpC alters transcription of hla and spa, we used qRT-PCR to determine the mRNA levels of hla and spa in strains DSM20231 and PBM001 both in vitro and after host cell invasion (Fig. 6 ). Consistent with previous observations 24 , during batch cultivation transcription of hla and spa was growth phase-dependent in strain DSM20231. Specifically, hla mRNA levels were most abundant late in the growth cycle (i.e., after 16 h of cultivation), while spa mRNA levels were elevated early in the growth cycle (i.e., after 3 h of cultivation). Similarly, transcription of hla and spa were growth phase dependent in the clpC mutant, although, hla and spa mRNA levels were greater in the clpC mutant relative to the wild-type strain. This latter observation is consistent with ClpCP affecting the stability of hla and spa mRNAs via degradation of the antitoxin MazE. To assess the hla and spa mRNA levels in internalized bacteria, EA.hy926 cells were infected and total RNA was isolated and used for qRT-PCR. At 90 minutes post-infection, hla and spa mRNA www.nature.com/scientificreports www.nature.com/scientificreports/ levels from internalized DSM20231 and PBM001 cells were equivalent between the wild-type and the clpC mutant. In contrast, after 96 h in EA.hy926 cells, clpC inactivated bacteria had significantly higher levels of spa mRNA, consistent with the hypothesis that ClpC affects transcription of spa via the control of MazEF activity. However, for hla mRNA levels, significantly more hla mRNA was found in DSM20231 cells that persisted for 96 h in EA.hy926 cells relative to that found in the clpC mutant (Fig. 6a ). Although this observation is consistent with the reduced survival of intracellular DSM20231 cells (Fig. 3) , it is inconsistent with the indication that ClpC controls hla transcription primarily via the modulation of MazEF activity. That being said, since transcription of hla is under multiple levels of control 19 , it cannot be excluded that ClpC might promote hla transcription under these conditions via cooperation with other regulatory elements, such as CcpA, CodY, Rex, and AgrA [25] [26] [27] [28] , all of which are substrates for ClpC in S. aureus 29 . One of the regulatory factors promoting hla transcription and being affected by ClpC is the response regulator AgrA of the agr locus 27, 29 . To determine whether ClpC alters transcription of the agr locus, we assessed the transcript levels of RNAIII, the main effector molecule of the agr locus 30 , in strains DSM20231 and PBM001 in vitro and after host cell invasion (Fig. 6c ). Consistent with previous observations, transcription of RNAIII was growth phase-dependent 31 . In batch culture grown DSM20231 cells, RNAIII transcript levels were low during exponential growth (3 h) , but increased in the later growth phase (16 h). In PBM001 cells, the clpC mutant produced a significantly greater amount of RNAIII in the exponential growth phase, relative to that of wild-type bacteria. In contrast to the exponential growth phase level of RNAIII, after 16 h of cultivation, PBM001 cells had very little RNAIII. In short-time internalized bacteria (i.e. after 90 minutes post-infection), RNAIII levels in DSM20231 and PBM001 cells were equivalent. In contrast, significantly more RNAIII was found in DSM20231 cells that persisted for 96 h in EA.hy926 cells relative to that found in the clpC mutant strain (Fig. 6c ), suggesting that ClpC enhances transcription of hla in intracellularly persisting DSM20231 cells. The simplest explanation for these data is that ClpC enhances transcription of the agr locus, causing an increase in RNAIII transcription, which in turn increases hla transcription. However, alternative regulatory circuits cannot be excluded.
Concluding remarks. The ability of S. aureus to invade host cells and to persist intracellularly is considered a major contributor to its ability to cause chronic diseases. We show here that inactivation of clpC in S. aureus augments the long-term intracellular survival in non-professional phagocytes, suggesting that ClpC modulates intracellular persistence. This is likely mediated, at least in part, due to an interaction of ClpC with AgrA, and to the ClpCP mediated degradation of MazE. Degradation of MazE activates the site-specific endoribonuclease MazF 13 , thereby inducing bacterial cell stasis 22 .
Materials and Methods
Bacterial strains, plasmids and culture conditions. Eukaryotic cell lines, bacterial strains, and plasmids used in this study are listed in Table 1 . Bacteria were routinely grown at 37 °C with 230 rpm of aeration in Brain Heart Infusion (BHI) broth or Luria Bertani (LB) broth purchased from Becton Dickinson (Heidelberg, Germany), using a culture medium-to-flask volume of 1:10. Where required, media were supplemented with (per milliliter): 10 µg erythromycin, or 10 µg tetracycline. HaCaT cells were cultured in MCDB153 Basal Medium (Biochrom AG, Berlin, Germany), 10% fetal bovine serum (FBS; PAA, Cölbel, Germany), and 1% non-essential amino acids (NEAA; Gibco, Darmstadt, Germany). EA.hy926 cells were cultivated in Dulbecco´s Modified Eagle Medium (Fisher Scientific, Schwerte, Germany) supplemented with 10% FBS. Both cell lines were grown in a humidified atmosphere at 37 °C and 5% CO 2 . Table 2 . Primers used in this study. a Restriction sites are underlined and specified in parentheses. Linker nucleotides are given as small letters.
